Pharmaceuticals

Immunohematology Market Forecast 2026–2035: How to Leverage Market Growth

February 16, 2026March 11, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the immunohematology market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Immunohematology Market reach by 2030 starting from 2026 levels?

The immunohematology market has experienced consistent growth in recent years. It is expected to expand from $2.56 billion in 2025 to $2.69 billion by 2026, registering a compound annual growth rate (CAGR) of 4.9%. This expansion in the past can be linked to factors such as the increasing prevalence of blood disorders, a heightened demand for safe blood transfusions, the establishment of blood banks, the proliferation of diagnostic laboratories, and progress in hematology reagents.

The immunohematology market is anticipated to experience substantial expansion over the upcoming years. Its valuation is projected to reach $3.27 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.0%. This projected growth during the forecast timeframe stems from several factors, including ongoing technological improvements in analyzers, the increasing adoption of AI in laboratory diagnostics, the emergence of precision medicine, the integration of digital health systems, and the broadening of blood screening initiatives. Key developments expected within this period involve advanced blood typing methods, enhanced automation in immunohematology testing, customized transfusion therapies, point-of-care immune diagnostic solutions, and the seamless integration of laboratory information systems.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

Which Drivers Are Influencing Long-Term Growth In The Immunohematology Market?

The immunohematology market is expected to experience growth primarily driven by the aging population. An aging population is a demographic phenomenon characterized by an increasing percentage of older individuals within a society. Immunohematology is crucial for addressing transfusion needs specific to older individuals, guaranteeing the safe application of blood products, and supporting various medical interventions required by this demographic. For instance, in January 2024, the Population Reference Bureau, a US-based nonprofit organization, indicated that the population of Americans aged 65 and older is projected to rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. During this same timeframe, this age group’s share of the overall population is also anticipated to climb from 17% to 23%. Therefore, the aging population serves as a significant catalyst for the expansion of the immunohematology market.

How Is The Immunohematology Market Divided Into Segments?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

How Are Emerging Trends Affecting The Progression Of The Immunohematology Market?

Leading firms within the immunohematology sector are concentrating on developing advanced diagnostic offerings, notably soluble recombinant proteins crafted to counteract the interference caused by the cancer therapy daratumumab. A soluble recombinant protein is a protein produced using recombinant DNA technology that sustains proper folding and functionality in a soluble state within a host cell or solution, thereby facilitating its application in research and medical treatments. For instance, in November 2023, Grifols, S.A., a pharmaceutical company based in Spain, launched its Grifols sCD38 solution. Grifols’ sCD38 stands as the pioneering soluble recombinant protein. It was created to address the interference daratumumab cancer therapy generates in essential blood transfusion compatibility tests. Specifically designed for individuals with multiple myeloma, this groundbreaking solution inhibits daratumumab from attaching to CD38 proteins on red blood cells, ensuring precise outcomes for pre-transfusion testing. By enabling a more efficient process for screening, identification, and crossmatching, Grifols sCD38 enhances blood transfusion protocols and minimizes delays in the delivery of life-saving transfusions.

Which Major Firms Are Strengthening Their Position In The Immunohematology Market?

Major companies operating in the immunohematology market are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Region Shows The Strongest Potential For Future Expansion In The Immunohematology Market?

North America was the largest region in the immunohematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Immunohematology Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp

Browse Through More Reports Similar to the Global Immunohematology Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunoassay Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Immunodiagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795